200 related articles for article (PubMed ID: 18179046)
1. Inoperable pancreatic cancer: standard of care.
Wisinski KB; Wahl AO; Small W; Benson AB
Oncology (Williston Park); 2007 Nov; 21(13):1558-64; discussion 1565, 1570-2. PubMed ID: 18179046
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy, combined radiochemotherapy and new therapeutic approaches in adenocarcinoma of the pancreas].
André T; Balosso J
J Chir (Paris); 1999 Dec; 136(6):309-17. PubMed ID: 10675820
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.
Yip D; Karapetis C; Strickland A; Steer CB; Goldstein D
Cochrane Database Syst Rev; 2006 Jul; (3):CD002093. PubMed ID: 16855985
[TBL] [Abstract][Full Text] [Related]
4. WITHDRAWN: Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.
Yip D; Karapetis C; Strickland A; Steer CB; Goldstein D
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD002093. PubMed ID: 19821291
[TBL] [Abstract][Full Text] [Related]
5. Clinical update of gemcitabine in pancreas cancer.
Au E
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():469-73. PubMed ID: 10895197
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group.
Ettrich TJ; Berger AW; Perkhofer L; Daum S; König A; Dickhut A; Wittel U; Wille K; Geissler M; Algül H; Gallmeier E; Atzpodien J; Kornmann M; Muche R; Prasnikar N; Tannapfel A; Reinacher-Schick A; Uhl W; Seufferlein T
BMC Cancer; 2018 Dec; 18(1):1298. PubMed ID: 30594153
[TBL] [Abstract][Full Text] [Related]
7. Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008.
Saif MW
JOP; 2008 Mar; 9(2):91-8. PubMed ID: 18326919
[TBL] [Abstract][Full Text] [Related]
8. The role of gemcitabine alone and in combination in the treatment of pancreatic cancer.
Oettle H; Arnold D; Hempel C; Riess H
Anticancer Drugs; 2000 Nov; 11(10):771-86. PubMed ID: 11142685
[TBL] [Abstract][Full Text] [Related]
9. Current Standard and Future Perspectives in First- and Second-Line Treatment of Metastatic Pancreatic Adenocarcinoma.
Ellenrieder V; König A; Seufferlein T
Digestion; 2016; 94(1):44-9. PubMed ID: 27438590
[TBL] [Abstract][Full Text] [Related]
10. Advancements in the management of pancreatic cancer: 2013.
Saif MW
JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of clinical factors and treatment results in patients with advanced pancreatic cancer.
Brasiūnas V; Brasiūniene B; Juozaityte E; Barauskas G
Medicina (Kaunas); 2004; 40(11):1074-80. PubMed ID: 15547308
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.
Cunningham SC; Cusnir M; Burdick RK; Van Echo DA; Moesinger R
Clin Adv Hematol Oncol; 2003 Dec; 1(12):741-2; discussion 743. PubMed ID: 16258479
[No Abstract] [Full Text] [Related]
13. [Chemoradiation for pancreatic adenocarcinoma].
Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
[TBL] [Abstract][Full Text] [Related]
14. How to treat pancreatic adenocarcinoma in elderly: How far can we go in 2017?
Gilabert M; Raoul JL; Rousseau F
J Geriatr Oncol; 2017 Nov; 8(6):407-412. PubMed ID: 28888554
[TBL] [Abstract][Full Text] [Related]
15. Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma.
Badiyan SN; Olsen JR; Lee AY; Yano M; Menias CO; Khwaja S; Wang-Gillam A; Strasberg SM; Hawkins WG; Linehan DC; Myerson RJ; Parikh PJ
Am J Clin Oncol; 2016 Feb; 39(1):1-7. PubMed ID: 26132367
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant strategies for pancreatic cancer.
Evans DB; Wolff RA; Crane CH
Oncology (Williston Park); 2001 Jun; 15(6):727-37; discussion 741-4, 747. PubMed ID: 11430206
[TBL] [Abstract][Full Text] [Related]
17. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
Regine WF; Winter KA; Abrams RA; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Kudrimoti MR; Fromm ML; Haddock MG; Schaefer P; Willett CG; Rich TA
JAMA; 2008 Mar; 299(9):1019-26. PubMed ID: 18319412
[TBL] [Abstract][Full Text] [Related]
18. Objective Assessment of Surgical Restaging after Concurrent Chemoradiation for Locally Advanced Pancreatic Cancer.
Paik WH; Lee SH; Kim YT; Park JM; Song BJ; Ryu JK
J Korean Med Sci; 2015 Jul; 30(7):917-23. PubMed ID: 26130955
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of multimodal treatment for patients with resectable carcinoma of the pancreas.
Okabayashi T; Nishimori I; Nishioka A; Yamashita K; Sugimoto T; Dabanaka K; Maeda H; Kohsaki T; Ogawa Y; Kobayashi M; Onishi S; Hanazaki K
Oncol Rep; 2008 Sep; 20(3):651-6. PubMed ID: 18695919
[TBL] [Abstract][Full Text] [Related]
20. Palliative chemotherapy for pancreatic malignancies.
Mehta SP
Surg Clin North Am; 2010 Apr; 90(2):365-75. PubMed ID: 20362792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]